[email protected] +91 9789129171
ICHSCT · Registering as Listener

International Conference on Hematology and Stem Cell Therapy

3 - 4 Mar 2027 Wellington, New Zealand Standard / Physical Participation
Listener Registration
$115
virtual · $175 in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.


Coupon code

Have a code? Apply it here — the discount updates the total immediately.


Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceICHSCT
ModeStandard / Physical
ParticipationListener
Registration fee$175.00
Bank charges (5.8%)$10.15
Total payable$185.15
Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

+91 9789129171

Benefits of Registering as Listener

Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
• Conference Session Tracks •
SDGs
SDG-Aligned Research Themes

ICHSCT conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 9 - Industry, Innovation and Infrastructure SDG 10 - Reduced Inequalities
01 Advancements in Hematology Research +
This track focuses on the latest discoveries and innovations in hematology, emphasizing molecular mechanisms and genetic factors influencing blood disorders. Participants will explore cutting-edge research that shapes the future of hematological science.
02 Stem Cell Therapy: Current Applications and Future Directions +
This session will delve into the evolving landscape of stem cell therapy, highlighting its applications in treating hematological malignancies. Discussions will include recent clinical trials and the potential for novel therapeutic strategies.
03 Bone Marrow Transplantation: Techniques and Outcomes +
This track will examine the latest techniques in bone marrow transplantation and their impact on patient outcomes. Experts will share insights on pre-transplant conditioning, donor selection, and post-transplant care.
04 Molecular Diagnostics in Hematology +
This session will explore the role of molecular diagnostics in the diagnosis and management of hematological disorders. Participants will discuss advancements in genomic technologies and their implications for personalized medicine.
05 Translational Research in Hematology +
This track focuses on bridging the gap between laboratory research and clinical practice in hematology. Attendees will learn about successful translational research initiatives that have led to improved therapeutic outcomes.
06 Patient Care in Hematological Disorders +
This session will address the multifaceted aspects of patient care for individuals with hematological conditions. Topics will include psychosocial support, patient education, and strategies for enhancing quality of life.
07 Clinical Outcomes in Hematology: Measuring Success +
This track will focus on methodologies for assessing clinical outcomes in hematology treatments. Participants will discuss the importance of outcome measures in evaluating the efficacy of therapeutic interventions.
08 Laboratory Innovations in Hematology +
This session will highlight recent technological advancements in laboratory practices relevant to hematology. Innovations in diagnostic tools and laboratory techniques will be discussed to enhance patient care.
09 Therapeutic Strategies in Hematological Malignancies +
This track will explore various therapeutic strategies employed in the treatment of hematological malignancies. Discussions will include chemotherapy, targeted therapies, and immunotherapy approaches.
10 Immunohematology: Advances and Challenges +
This session will focus on the latest advancements in immunohematology, including blood group serology and transfusion medicine. Participants will discuss challenges faced in the field and potential solutions to improve patient safety.
11 Ethical Considerations in Hematology and Stem Cell Therapy +
This track will address the ethical dilemmas and considerations surrounding hematology and stem cell therapy. Experts will engage in discussions about informed consent, equity in access to treatments, and the implications of emerging technologies.